NASDAQ:BCRX

BioCryst Pharmaceuticals SEC Filings & 10K Form

$12.92
+2.24 (+20.97 %)
(As of 05/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.86
$13.28
50-Day Range
$9.50
$13.24
52-Week Range
$3.30
$14.24
Volume17.85 million shs
Average Volume6.25 million shs
Market Capitalization$2.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.03

SEC Filings

BioCryst Pharmaceuticals (NASDAQ:BCRX) SEC Filings

DateFilerForm TypeView
05/06/2021
6:09 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
6:09 AM
BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
9:57 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2021
7:21 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2021
8:36 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
04/02/2021
4:26 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2021
1:02 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2021
7:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2021
3:41 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
3:53 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:50 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:47 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2021
8:19 AM
BioCryst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
3:40 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
3:34 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
3:25 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:16 PM
BioCryst Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/11/2021
11:54 AM
BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/10/2021
3:28 PM
BioCryst Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
02/05/2021
10:42 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/03/2021
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:43 PM
BioCryst Pharmaceuticals (Subject)
Sarissa Capital Management LP (Filed by)
Form SC 13G
01/22/2021
6:12 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2020
7:16 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2020
6:03 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2020
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
3:45 PM
BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:41 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:37 PM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:32 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:30 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:27 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:23 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:20 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
4:35 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
6:14 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
12/08/2020
3:12 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:24 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:23 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:21 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:19 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:16 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:34 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
8:34 AM
BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
3:21 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:19 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:16 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:14 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
3:25 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:12 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
6:10 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2020
3:44 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:39 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:36 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:33 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
10:21 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
6:04 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2020
3:35 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/12/2020
3:31 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
6:25 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
6:14 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2020
4:07 PM
BioCryst Pharmaceuticals (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SC 13G
06/10/2020
3:32 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2020
3:32 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2020
3:31 PM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/01/2020
7:30 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
5:07 AM
BioCryst Pharmaceuticals (Filer)
Form 424B2
05/27/2020
4:16 PM
BioCryst Pharmaceuticals (Filer)
Form 424B5
05/15/2020
3:20 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
11:15 PM
BioCryst Pharmaceuticals (Filer)
Form EFFECT
05/14/2020
3:36 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
3:21 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
3:18 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:15 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
7:55 AM
BioCryst Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2020
4:30 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioCryst Pharmaceuticals (Subject)
Form SC 13G
04/09/2020
7:11 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
9:51 AM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2020
6:55 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
11:53 AM
BioCryst Pharmaceuticals (Filer)
Form DEFA14A
03/31/2020
11:52 AM
BioCryst Pharmaceuticals (Filer)
Form DEF 14A
03/30/2020
6:20 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2020
3:15 PM
BioCryst Pharmaceuticals (Filer)
Form PRE 14A
03/13/2020
2:36 PM
BioCryst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2020
8:26 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
6:24 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
6:24 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
3:49 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
3:42 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:13 PM
BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:11 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:57 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:53 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:07 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:20 PM
BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
02/14/2020
3:14 PM
BAKER BROS. ADVISORS LP (Filed by)
BioCryst Pharmaceuticals (Subject)
Form SC 13G/A
This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.